Publications by authors named "F Froeling"

Claim this Profile
D
Demographics of epithelioid trophoblastic tumour and placental site trophoblastic tumour: a 21 year UK population study.
P Savage, F Froeling, M Lythgoe, R Fisher, G Maher

J Obstet Gynaecol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.
Jennifer J Knox, Grainne O'Kane, Daniel King, Daniel Laheru, Amber N Habowski, Fieke E M Froeling

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.
Jennifer J Knox, Grainne O'Kane, Daniel King, Daniel Laheru, Amber N Habowski, Fieke E M Froeling

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinoma.
Katharine J Herbert, Rosie Upstill-Goddard, Stephan B Dreyer, Selma Rebus, Christian Pilarsky, Fieke E M Froeling

Br J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol: multi-centre, randomised controlled clinical trial exploring stromal targeting in locally advanced pancreatic cancer; STARPAC2.
Hemant M Kocher, , , , Peter Sasieni, Fieke E M Froeling

BMC Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis